Justices Told 'Skinny Label' Case Puts Generic Drugs At Risk
By Ryan Davis · February 26, 2026, 8:11 PM EST
The U.S. government, one named sponsor of the Hatch-Waxman Act, a generic-drug industry group and more have warned the U.S. Supreme Court that a decision that allowed a patent case involving...
To view the full article, register now.